YIH
GPCR icon

Y-Intercept (HK)’s Structure Therapeutics GPCR Stock Holding History

Y-Intercept (HK)’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.48M Buy
+27,573
New +$1.22M 0.03% 864
2026
Q1 		– Sell
-10,132
Closed -$705K – 1750
2025
Q4 		$705K Buy
+10,132
New +$414K 0.02% 1124
2024
Q4 		– Sell
-40,706
Closed -$1.79M – 1369
2024
Q3 		$1.79M Buy
+40,706
New +$1.57M 0.11% 241
2024
Q2 		– Sell
-4,867
Closed -$209K – 1578
2024
Q1 		$209K Buy
+4,867
New +$205K 0.02% 1137

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Y-Intercept (HK)'s GPCR Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 27,573 shares worth $1.48M. The stake represents 0.03% of the portfolio and ranks #864 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in GPCR as recently as Q4 2025.

Y-Intercept (HK) first reported a position in GPCR in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.79M in Q3 2024. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Y-Intercept (HK) held 27,573 shares of Structure Therapeutics worth $1.48M as of Q2 2026.
  • Structure Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
  • Structure Therapeutics made up 0.03% of Y-Intercept (HK)'s portfolio in Q2 2026, its #864 holding.
  • Y-Intercept (HK) first reported a position in Structure Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Y-Intercept (HK)'s Structure Therapeutics position peaked at $1.79M in Q3 2024.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.